Guidance and Manufacturer’s Declaration – Electromagnetic Emissions and Immunity

Guidance and manufacturer’s declaration – electromagnetic emissions

The VPAP Auto 25, VPAP ST and VPAP S devices are intended for use in the electromagnetic environment specified below. The customer or the user of the VPAP device should assure that the device is used in such an environment.

Emissions test

Compliance

Electromagnetic environment – guidance

 

 

 

RF emissions CISPR11

Group 1

The VPAP device uses RF energy only for its

 

 

internal function. Therefore, its RF emissions are

 

 

very low and are not likely to cause any

 

 

interference in nearby electronic equipment.

 

 

 

RF emissions CISPR 11 with serial adapter

Class B

The VPAP device is suitable for use in all

 

 

establishments, including domestic

 

 

RF emissions CISPR 11 with USB adapter

Class B

establishments and those directly connected to

 

 

the public low-voltage network that supplies

 

 

Harmonic Emissions IEC 61000-3-2

Class A

buildings used for domestic purposes.

 

 

 

 

Voltage Fluctuations/Flicker Emissions IEC

Complies

 

61000-3-3

 

 

 

 

 

Warnings: The VPAP device should not be used adjacent to or stacked with other equipment.

If adjacent or stacked use is necessary, the VPAP device should be observed to verify normal operation in the configuration in which it will be used. The use of accessories (eg, humidifiers) other than those specified in this manual is not recommended. They may result in increased emissions or decreased immunity of the VPAP device.

Recommended separation distances between portable and mobile RF communications equipment and the VPAP series of devices

The VPAP device is intended for use in an environment in which radiated RF disturbances are controlled. The customer or the user of the VPAP device can help prevent electromagnetic interference by maintaining a minimum distance between portable and mobile RF communications equipment (transmitters) and the VPAP device as recommended below, according to the maximum output power of the communications equipment.

Separation distance according to frequency of transmitter (m)

Rated maximum output

150 kHz to 80 MHz

80 MHz to 800 MHz

800 MHz to 2.5 GHz

power of transmitter (W)

d = 1.17 P

d = 0.35 P

d = 0.7 P

 

 

 

 

0.01

0.17

0.04

0.07

 

 

 

 

0.1

0.37

0.11

0.22

 

 

 

 

1

1.17

0.35

0.7

 

 

 

 

10

3.69

1.11

2.21

 

 

 

 

100

11.70

3.50

7.0

 

 

 

 

For transmitters rated at a maximum output power not listed above, the recommended separation distance d in metres (m) can be determined using the equation applicable to the frequency of the transmitter, where P is the maximum output power rating of the transmitter in watts (W) according to the transmitter manufacturer.

NOTE 1: At 80 MHz and 800 MHz, the separation distance for the higher frequency range applies.

NOTE 2: These guidelines may not apply in all situations. Electromagnetic propagation is affected by absorption and reflection from structures, objects and people.

English

General Warnings and Cautions

17

Page 20
Image 20
ResMed ST, AUTO 25 manual General Warnings and Cautions, Separation distance according to frequency of transmitter m

AUTO 25, ST, S specifications

The ResMed S, ST, and AUTO 25 devices represent a significant advancement in sleep therapy technology, designed to enhance the treatment of patients with obstructive sleep apnea (OSA) and other sleep-related disorders. These devices are part of ResMed's commitment to improving patient outcomes through innovative breathing solutions.

One of the standout features of the ResMed S, ST, and AUTO 25 is their adaptive pressure support capabilities. The devices utilize advanced algorithms to automatically adjust air pressure based on the user’s breathing patterns. This real-time responsiveness ensures that patients receive optimal therapy tailored to their specific needs, allowing for a more comfortable and effective treatment experience.

The automatic titration feature of the AUTO 25 is particularly noteworthy. It continuously monitors the patient’s airflow and adjusts pressure levels throughout the night. This dynamic capability not only enhances compliance but also helps to prevent apnea events more effectively than fixed-pressure devices.

In terms of comfort, the ResMed S, ST, and AUTO 25 feature a ramp function that gradually increases pressure from a lower starting point. This allows patients to fall asleep more comfortably before reaching the prescribed therapeutic pressure. The quiet operation of these devices adds to patient comfort, ensuring a peaceful night’s sleep for both the user and their partner.

Connectivity is another key characteristic of the ResMed S, ST, and AUTO 25 devices. Equipped with wireless technology, these devices allow for seamless data transfer to healthcare providers. This connectivity facilitates remote monitoring, enabling clinicians to track therapy progress and make necessary adjustments without the need for in-person visits.

Additionally, the user-friendly interface simplifies setup and navigation. Intuitive controls and a clear display make it easy for users to monitor their therapy progress and understand their treatment journey. The devices are designed with patient education in mind, providing users with essential information about their sleep patterns and therapy effectiveness.

ResMed also places a strong emphasis on the durability and reliability of its devices. The S, ST, and AUTO 25 are constructed with high-quality materials and are rigorously tested to ensure long-lasting performance. Maintenance is straightforward, with easily accessible components to facilitate cleaning and upkeep.

In summary, the ResMed S, ST, and AUTO 25 devices represent a comprehensive solution for sleep therapy, combining innovative technologies, user-friendly features, and reliable performance to improve patient care. Their intelligent adaptability, advanced monitoring, and enhanced comfort make them a preferred choice for individuals seeking effective treatment for sleep disorders. With ResMed’s ongoing commitment to research and development, patients can expect even greater advancements in sleep therapy solutions in the future.